Skip to main content

Advertisement

Log in

The Safety, Efficacy, and Potential Complications of Intracameral Antibiotics

  • Ocular Microbiology and Immunology (B Jeng and L Schocket, Section Editors)
  • Published:
Current Ophthalmology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The use of intracameral antibiotics (ICAs) as endophthalmitis prophylaxis after cataract surgery has increased in the past decade. The goal of this paper is to review the current literature arguing for and against ICAs.

Recent Findings

There is compelling evidence that ICAs have greater efficacy than topical antibiotics in preventing post-operative endophthalmitis. However, issues related to availability, cost, and safety have limited their widespread adoption in countries such as the USA.

Summary

In countries without access to a commercially available prepackaged antibiotic for intracameral use, cataract surgeons will have to individually weigh the risks and benefits of ICAs in determining their method of endophthalmitis prophylaxis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Garg P, Roy A, Sharma S. Endophthalmitis after cataract surgery: epidemiology, risk factors, and evidence on protection. Curr Opin Ophthalmol. 2017;28(1):67–72. https://doi.org/10.1097/ICU.0000000000000326.

    Article  PubMed  Google Scholar 

  2. Friling E, Lundstrom M, Stenevi U, Montan P. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg. 2013;39(1):15–21. https://doi.org/10.1016/j.jcrs.2012.10.037.

    Article  PubMed  Google Scholar 

  3. Grzybowski A, Kanclerz P, Myers WG. The use of povidone-iodine in ophthalmology. Curr Opin Ophthalmol. 2017;29:19–32. https://doi.org/10.1097/ICU.0000000000000437.

    Article  Google Scholar 

  4. Grzybowski A, Kuklo P, Pieczynski J, Beiko G. A review of preoperative manoeuvres for prophylaxis of endophthalmitis in intraocular surgery: topical application of antibiotics, disinfectants, or both? Curr Opin Ophthalmol. 2016;27(1):9–23. https://doi.org/10.1097/ICU.0000000000000216.

    Article  PubMed  Google Scholar 

  5. Huang J, Wang X, Chen X, Song Q, Liu W, Lu L. Perioperative antibiotics to prevent acute endophthalmitis after ophthalmic surgery: a systematic review and meta-analysis. PLoS One. 2016;11(11):e0166141. https://doi.org/10.1371/journal.pone.0166141.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Balestrazzi A, Malandrini A, Montagnani F, Nguisseu Chegoua GL, Ciompi L, Zanchi A, et al. Phacoemulsificator and sterile drapes contamination during cataract surgery: a microbiological study. Eur J Ophthalmol. 2012;22(2):188–94. https://doi.org/10.5301/EJO.2011.8434.

    Article  PubMed  Google Scholar 

  7. Endophthalmitis Study Group ESoC. Refractive S. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978–88. https://doi.org/10.1016/j.jcrs.2007.02.032.

    Article  Google Scholar 

  8. Chang DF, Braga-Mele R, Henderson BA, Mamalis N, Vasavada A, Committee ACC. Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2014 ASCRS member survey. J Cataract Refract Surg. 2015;41(6):1300–5. https://doi.org/10.1016/j.jcrs.2015.01.014.

    Article  PubMed  Google Scholar 

  9. Barry P. Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: update on the ESCRS Endophthalmitis Study. J Cataract Refract Surg. 2014;40(1):138–42. https://doi.org/10.1016/j.jcrs.2013.11.002.

    Article  PubMed  Google Scholar 

  10. Herrinton LJ, Shorstein NH, Paschal JF, Liu L, Contreras R, Winthrop KL, et al. Comparative effectiveness of antibiotic prophylaxis in cataract surgery. Ophthalmology. 2016;123(2):287–94. https://doi.org/10.1016/j.ophtha.2015.08.039.

    Article  PubMed  Google Scholar 

  11. Haripriya A, Chang DF, Namburar S, Smita A, Ravindran RD. Efficacy of intracameral moxifloxacin endophthalmitis prophylaxis at Aravind Eye Hospital. Ophthalmology. 2016;123(2):302–8. https://doi.org/10.1016/j.ophtha.2015.09.037.

    Article  PubMed  Google Scholar 

  12. Haripriya A, Chang DF, Ravindran RD. Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: analysis of 600 000 surgeries. Ophthalmology. 2017;124(6):768–75. https://doi.org/10.1016/j.ophtha.2017.01.026.

    Article  PubMed  Google Scholar 

  13. Cao H, Zhang L, Li L, Lo S. Risk factors for acute endophthalmitis following cataract surgery: a systematic review and meta-analysis. PLoS One. 2013;8(8):e71731. https://doi.org/10.1371/journal.pone.0071731.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Kessel L, Flesner P, Andresen J, Erngaard D, Tendal B, Hjortdal J. Antibiotic prevention of postcataract endophthalmitis: a systematic review and meta-analysis. Acta Ophthalmol. 2015;93(4):303–17. https://doi.org/10.1111/aos.12684.

    Article  PubMed  Google Scholar 

  15. Linertova R, Abreu-Gonzalez R, Garcia-Perez L, Alonso-Plasencia M, Cordoves-Dorta LM, Abreu-Reyes JA, et al. Intracameral cefuroxime and moxifloxacin used as endophthalmitis prophylaxis after cataract surgery: systematic review of effectiveness and cost-effectiveness. Clin Ophthalmol. 2014;8:1515–22. https://doi.org/10.2147/OPTH.S59776.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Naseri A, Melles RB, Shorstein NH. Intracameral antibiotics in the shadow of hemorrhagic occlusive retinal vasculitis. Ophthalmology. 2017;124(5):580–2. https://doi.org/10.1016/j.ophtha.2017.02.019.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Schwartz SG, Grzybowski A, Flynn HW Jr. Antibiotic prophylaxis: different practice patterns within and outside the United States. Clin Ophthalmol. 2016;10:251–6. https://doi.org/10.2147/OPTH.S100429.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Kim SJ, Toma HS. Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections. Ophthalmology. 2011;118(7):1358–63. https://doi.org/10.1016/j.ophtha.2010.12.014.

    Article  PubMed  Google Scholar 

  19. Braga-Mele R, Chang DF, Henderson BA, Mamalis N, Talley-Rostov A, Vasavada A, et al. Intracameral antibiotics: safety, efficacy, and preparation. J Cataract Refract Surg. 2014;40(12):2134–42. https://doi.org/10.1016/j.jcrs.2014.10.010.

    Article  PubMed  Google Scholar 

  20. Nicholson LB, Kim BT, Jardon J, Townsend-Pico W, Santos C, Moshfeghi AA, et al. Severe bilateral ischemic retinal vasculitis following cataract surgery. Ophthalmic Surg Lasers Imaging Retina. 2014;45(4):338–42. https://doi.org/10.3928/23258160-20140605-01.

    Article  PubMed  Google Scholar 

  21. Witkin AJ, Chang DF, Jumper JM, Charles S, Eliott D, Hoffman RS, et al. Vancomycin-associated hemorrhagic occlusive retinal vasculitis: clinical characteristics of 36 eyes. Ophthalmology. 2017;124(5):583–95. https://doi.org/10.1016/j.ophtha.2016.11.042.

    Article  PubMed  Google Scholar 

  22. Administration USFD. Compounded Triamicinolone and Moxifloxacin Product for Intravitreal Injection by Guardian Pharmacy Services: Alert to Health Professionals - Serious Adverse Events Reported. 2017. https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm569123.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery. Accessed October 24th, 2017.

  23. Administration USFD. A case of hemorrhagic occlusive retinal vasculitis (HORV) following intraocular injections of a compounded triamcinolone, moxifloxacin, and vancomycin formulation. https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm578514.htm. Accessed 7 February 2018.

  24. Todorich B. New Insights in Vancomycin-associated Hemorrhagic Occlusive Retinal Vasculopathy (HORV). Retina Society Annual Meeting; Boston, MA October 5, 2017.

  25. Arshinoff SA, Modabber M. Dose and administration of intracameral moxifloxacin for prophylaxis of postoperative endophthalmitis. J Cataract Refract Surg. 2016;42(12):1730–41. https://doi.org/10.1016/j.jcrs.2016.10.017.

    Article  PubMed  Google Scholar 

  26. Delyfer MN, Rougier MB, Leoni S, Zhang Q, Dalbon F, Colin J, et al. Ocular toxicity after intracameral injection of very high doses of cefuroxime during cataract surgery. J Cataract Refract Surg. 2011;37(2):271–8. https://doi.org/10.1016/j.jcrs.2010.08.047.

    Article  PubMed  Google Scholar 

  27. Cakir M, Imamoglu S, Cekic O, Bozkurt E, Alagoz N, Oksuz L, et al. An outbreak of early-onset endophthalmitis caused by Fusarium species following cataract surgery. Curr Eye Res. 2009;34(11):988–95. https://doi.org/10.3109/02713680903254822.

    Article  PubMed  CAS  Google Scholar 

  28. Mamalis N, Edelhauser HF, Dawson DG, Chew J, LeBoyer RM, Werner L. Toxic anterior segment syndrome. J Cataract Refract Surg. 2006;32(2):324–33. https://doi.org/10.1016/j.jcrs.2006.01.065.

    Article  PubMed  Google Scholar 

  29. Schwartz SG, Flynn HW Jr, Grzybowski A, Relhan N, Ferris FL 3rd. Intracameral antibiotics and cataract surgery: endophthalmitis rates, costs, and stewardship. Ophthalmology. 2016;123(7):1411–3. https://doi.org/10.1016/j.ophtha.2016.03.024.

    Article  PubMed  Google Scholar 

  30. O'Brien TP, Arshinoff SA, Mah FS. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. J Cataract Refract Surg. 2007;33(10):1790–800. https://doi.org/10.1016/j.jcrs.2007.06.026.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andre J. Witkin.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Ocular Microbiology and Immunology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tye, A., Witkin, A.J. The Safety, Efficacy, and Potential Complications of Intracameral Antibiotics. Curr Ophthalmol Rep 6, 152–156 (2018). https://doi.org/10.1007/s40135-018-0174-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40135-018-0174-3

Keywords

Navigation